While continuous glucose monitors are part of routine care for people with type 1 diabetes, there are many other people who may also benefit from real-time insight into glucose levels. Experts ...

Salt is essential for regulating important body functions, but too much can be harmful. Here are some strategies to reduce sodium in your diet. If you live with a chronic condition like diabetes, high ...

CagriSema is a once-weekly injection of semaglutide and cagrilintide. Clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a ...

People with diabetes who are also a part of the LGBTQ community face unique challenges when it comes to healthcare, dealing with stigma and body image issues. Shawn Laib describes his personal ...

Key takeaways: Finerenone (brand name Kerendia) is an oral medication approved for people with chronic kidney disease and type 2 diabetes. New research shows that finerenone also reduces the risk of ...

Key takeaways: People with type 2 diabetes who took SGLT-2 inhibitors saw significantly lower rates of dementia and Parkinson's disease. Studies have shown that other diabetes drugs, including ...

In the world of diabetes management, one size does not fit all. Doing Diabetes Your Way is an ongoing video series that offers accessible, relatable content that encourages individuals to manage ...

Former NFL player and veteran sports reporter Mike Golic talks about creating an individual treatment plan to best fit your needs, how he uses diabetes technology, and how having conversations about ...

Why is this study important? This study is testing endoscopic intestinal re-cellularization (ReCET) therapy to see if it can help people with type 2 diabetes improve their blood sugar management. The ...

The mylife CamAPS FX hybrid closed-loop system has been shown to significantly improve blood sugar management and quality of life for people with type 1 diabetes of all ages. In very young children ...

This clinical trial is testing whether IcoSema, a new once-weekly insulin injection combined with semaglutide, can help people with type 2 diabetes better manage their glucose levels and lose weight.

While AID has traditionally been used in type 1 diabetes, new data suggests this technology has many of the same benefits in type 2 – namely, improving time in range and A1C while reducing ...